Overview
Swathi Namburi, MD, is a hematologist who specializes in treating a variety of blood cancer and blood disorders. Her clinical research interests include multiple myeloma and novel immunotherapy approaches for blood cancers. Dr. Namburi is part of the Center for Blood Disorders and Cellular Therapy at the Swedish Cancer Institute. She provides full-spectrum care for her patients. This includes initial consultation and diagnosis, treatment to help achieve remission, consideration and enrollment onto clinical trials open through Providence/Swedish health care, and long-term management and survivorship related care. She oversees her patients through CAR-T cell therapy and autologous stem cell transplantation as these needs come up during various phases of treatment. Dr. Namburi completed a fellowship in hematology/oncology at the University of Pittsburgh Medical Center. She completed her residency at the George Washington University Medical Center in DC, and prior to that attended medical school at Rutgers/UMDNJ in New Brunswick, NJ near to where she grew up in East Brunswick, NJ. She is board certified in internal medicine, medical oncology, and hematology. She can communicate in several languages including Telugu, Hindi, Spanish, and French and she liberally receives help from Swedish’s wonderful in-person medical translators. Dr. Namburi has been practicing in the Seattle-Tacoma region since 2018. She is a board member of the Washington State Medical Oncology Society and participates in the annual Washington State Medical Association meetings to help support state initiatives that will help our patients with cancer have access to excellent care and treatment. She regularly attends and presents her work at national and international hematology conferences.
Dr. Namburi is rated as an Experienced provider by MediFind in the treatment of HELLP Syndrome. Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Multiple Myeloma, Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.
Her clinical research consists of co-authoring 8 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 8 articles and participated in 2 clinical trials in the study of HELLP Syndrome.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1221 Madison Street, Floor 10, Seattle, WA 98104
747 Broadway, Seattle, WA 98122
Additional Areas of Focus
Dr. Namburi has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Pacific Medical Centers Specialty Care - Totem Lake
I believe in developing a relationship with my patients so that we can work together to treat their disease. Dr. Ahmed is a mentor for University of Washington medical residents. Dr. Ahmed's medical interests include: breast cancer, prostate cancer, kidney cancer and bladder cancer. Dr. Ahmed is rated as an Experienced provider by MediFind in the treatment of HELLP Syndrome. Her top areas of expertise are Small Lymphocytic Lymphoma (SLL), Angiosarcoma, Inflammatory Breast Cancer, and Morning Sickness.
The Polyclinic Madison Center - Oncology & Hematology
My philosophy is to consider the patient a partner in health care and to involve him/her in discussions and decisions regarding treatment and prevention of disease. Dr. Li is rated as an Experienced provider by MediFind in the treatment of HELLP Syndrome. His top areas of expertise are Aase Syndrome, Metachondromatosis, Syndactyly Cenani Lenz Type, and X-Linked Severe Combined Immunodeficiency.
Center For Blood Disorders And Stem Cell Transplantation
Dr. Egan specializes in the care of patients with hematologic malignancies including leukemia, myelodysplastic syndrome, myeloproliferative disorders, as well as blood disorders such as anemia. His holistic partnership approach to treatment ensures patients are involved in decision-making that focuses on what is most important to them. Dr. Egan provides thorough education so patients can confidently understand their illness and treatment options, and helps patients navigate the variety of existing and emerging therapies. Dr. Egan is rated as a Distinguished provider by MediFind in the treatment of HELLP Syndrome. His top areas of expertise are Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)Dr. Namburi isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Large-Cell Immunoblastic LymphomaDr. Namburi isAdvanced. Learn about Large-Cell Immunoblastic Lymphoma.
- Multiple MyelomaDr. Namburi isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Namburi isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Adult Immune ThrombocytopeniaDr. Namburi isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Namburi isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Namburi isExperienced. Learn about Anaplastic Large Cell Lymphoma.